202 related articles for article (PubMed ID: 26745876)
1. Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy.
Thomsen KL; Macnaughtan J; Tritto G; Mookerjee RP; Jalan R
PLoS One; 2016; 11(1):e0146076. PubMed ID: 26745876
[TBL] [Abstract][Full Text] [Related]
2. Bacterial DNA Translocation Is Associated With Overt Hepatic Encephalopathy and Mortality in Patients With Cirrhosis.
Thanapirom K; Suksawatamnuay S; Wejnaruemarn S; Thaimai P; Siripon N; Ananchuensook P; Sriphoosanaphan S; Vanichanan J; Treeprasertsuk S; Poovorawan Y; Komolmit P
Clin Transl Gastroenterol; 2024 May; 15(5):e00697. PubMed ID: 38488171
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
Nardelli S; Gioia S; Ridola L; Farcomeni A; Merli M; Riggio O
Hepatology; 2019 Aug; 70(2):640-649. PubMed ID: 30289992
[TBL] [Abstract][Full Text] [Related]
4. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy.
Moratalla A; Ampuero J; Bellot P; Gallego-Durán R; Zapater P; Roger M; Figueruela B; Martínez-Moreno B; González-Navajas JM; Such J; Romero-Gómez M; Francés R
Liver Int; 2017 Feb; 37(2):212-223. PubMed ID: 27388776
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
Labenz C; Baron JS; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
Aliment Pharmacol Ther; 2018 Aug; 48(3):313-321. PubMed ID: 29863286
[TBL] [Abstract][Full Text] [Related]
6. [Minimal hepatic encephalopathy: a better diagnostic to improve prognostic].
Ennaifer R; Cheikh M; Hefaiedh R; Romdhane H; Ben Nejma H; Hadj NB
Presse Med; 2014 May; 43(5):e127-33. PubMed ID: 24703736
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.
Hanai T; Shiraki M; Watanabe S; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
J Gastroenterol Hepatol; 2019 Oct; 34(10):1809-1816. PubMed ID: 30779213
[TBL] [Abstract][Full Text] [Related]
8. Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study.
Weiss N; Tripon S; Lodey M; Guiller E; Junot H; Monneret D; Mayaux J; Brisson H; Mallet M; Rudler M; Imbert-Bismut F; Thabut D;
Fundam Clin Pharmacol; 2018 Apr; 32(2):209-215. PubMed ID: 29239015
[TBL] [Abstract][Full Text] [Related]
9. Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes.
Abid S; Kamran M; Abid A; Butt N; Awan S; Abbas Z
Sci Rep; 2020 Jun; 10(1):10079. PubMed ID: 32572109
[TBL] [Abstract][Full Text] [Related]
10. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
[TBL] [Abstract][Full Text] [Related]
11. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy.
Romero-Gómez M; Grande L; Camacho I; Benitez S; Irles JA; Castro M
J Hepatol; 2002 Dec; 37(6):781-7. PubMed ID: 12445419
[TBL] [Abstract][Full Text] [Related]
12. Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis.
Yuan LT; Chuah SK; Yang SC; Liang CM; Wu CK; Tai WC; Hung TH; Nguang SH; Wang JW; Tseng KL; Ku MK; Hsu PI; Wu DC; Hsu CN
PLoS One; 2018; 13(5):e0197127. PubMed ID: 29746564
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Helicobacter pylori Infection in Patients with Minimal Hepatic Encephalopathy.
Schulz C; Schütte K; Reisener N; Voss J; Malfertheiner P
J Gastrointestin Liver Dis; 2016 Jun; 25(2):191-5. PubMed ID: 27308650
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial.
Maharshi S; Sharma BC; Sachdeva S; Srivastava S; Sharma P
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):454-460.e3; quiz e33. PubMed ID: 26453952
[TBL] [Abstract][Full Text] [Related]
15. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
[TBL] [Abstract][Full Text] [Related]
16. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.
Shawcross DL; Sharifi Y; Canavan JB; Yeoman AD; Abeles RD; Taylor NJ; Auzinger G; Bernal W; Wendon JA
J Hepatol; 2011 Apr; 54(4):640-9. PubMed ID: 21163546
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patients.
Philonenko S; Rivière P; Mallet M; Poullenot F; Tripon S; Munteanu M; Boukherrouf R; Sultanik P; Roupret M; Thabut D; Rudler M
Dig Liver Dis; 2019 Jun; 51(6):850-855. PubMed ID: 31031175
[TBL] [Abstract][Full Text] [Related]
18. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
[TBL] [Abstract][Full Text] [Related]
19. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
Ampuero J; Montoliú C; Simón-Talero M; Aguilera V; Millán R; Márquez C; Jover R; Rico MC; Sendra C; Serra MÁ; Romero-Gómez M
J Gastroenterol Hepatol; 2018 Mar; 33(3):718-725. PubMed ID: 28768371
[TBL] [Abstract][Full Text] [Related]
20. The animal naming test: An easy tool for the assessment of hepatic encephalopathy.
Campagna F; Montagnese S; Ridola L; Senzolo M; Schiff S; De Rui M; Pasquale C; Nardelli S; Pentassuglio I; Merkel C; Angeli P; Riggio O; Amodio P
Hepatology; 2017 Jul; 66(1):198-208. PubMed ID: 28271528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
